ROYAL BANK OF CANADA - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 125 filers reported holding IMMUNOVANT INC in Q1 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$1,537,000
+1751.8%
40,041
+820.7%
0.00%
Q2 2023$83,000
+38.3%
4,349
+12.1%
0.00%
Q1 2023$60,000
-45.0%
3,879
-37.2%
0.00%
Q4 2022$109,000
+1111.1%
6,176
+300.8%
0.00%
Q3 2022$9,000
+80.0%
1,541
+21.7%
0.00%
Q2 2022$5,000
-75.0%
1,266
-64.2%
0.00%
Q1 2022$20,000
-73.0%
3,533
-59.0%
0.00%
Q4 2021$74,000
+94.7%
8,626
+96.1%
0.00%
Q3 2021$38,000
+15.2%
4,398
+41.5%
0.00%
Q2 2021$33,000
-13.2%
3,109
+32.2%
0.00%
Q1 2021$38,000
-59.6%
2,351
+15.5%
0.00%
Q4 2020$94,000
+56.7%
2,035
+20.3%
0.00%
Q3 2020$60,000
+5900.0%
1,691
+3926.2%
0.00%
Q2 2020$1,000420.00%
Other shareholders
IMMUNOVANT INC shareholders Q1 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders